JUNKO TANAKA

Last Updated :2022/08/02

Affiliations, Positions
Medical Policy Office, Executive and Vice President
E-mail
jun-tanakahiroshima-u.ac.jp
Other Contact Details
1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
TEL : (+81)82-257-5160 FAX : (+81)82-257-5164
Self-introduction
Graduate School of Medical Sciences, Epidemiology and Disease Control. In my laboratory, in order to prevent diseases and control countermeasures, I am conducting theoretical epidemiological research at the same time as laboratory research, and pursuing evidence that leads to policy proposals. We conduct NDB analysis, theoretical epidemiology, cost-effectiveness, medical statistics, simulation, viral gene analysis, immunoserology, standardization of measurement system, and epidemiology research related to blood business. In hepatitis virus research, we are conducting epidemiological surveys in Japan and overseas such as Cambodia and Brukina Faso to take measures against hepatitis and liver cancer. Epidemiological research on the new coronavirus has also begun. It is also important to develop human resources in the fields of epidemiology and disease control through the education of MPH School of Public Health and PhD.

Basic Information

Major Professional Backgrounds

  • 1981/11/24, 1987/03/31, Hiroshima University, Faculty of Medicine, Research Associate
  • 1990/04/01, 1995/07/31, Hiroshima University, Faculty of Medicine, Research Associate
  • 1990/04/01, 1995/07/31, Hiroshima University, Faculty of School Education, part-time lecturer
  • 1991/03/01, 1991/08/31, University of Minnesota, School of Public Health, Division of Biostatistics, Visiting Assistant Professor
  • 1995/08/01, 2002/03/31, Hiroshima University, Faculty of Medicine, Lecturer
  • 1995/08/01, 2000/03/31, Hiroshima University, Faculty of School Education, Lecturer
  • 2002/04/01, 2004/05/31, Hiroshima University, Graduate School of Biomedical Sciences, Lecturer
  • 2004/06/01, 2007/03/31, Hiroshima University, Graduate School of Biomedical Sciences, Assistant Professor
  • 2007/04/01, 2009/02/28, Hiroshima University, Graduate School of Biomedical Sciences, Associate Professor
  • 2009/03/01, Hiroshima University, Graduate School of Biomedical Sciences, Professor
  • 2012/11, Hiroshima University Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Director
  • 2019/04/01, Project Research Center For epidemiological & mega-data analysis of New research area, Director
  • 2020/04/01, Health Policy Office, Executive Director / Executive Vice-President

Educational Backgrounds

  • Ochanomizu University, Faculty of Science, Mathmatics, Japan, 1976/04, 1980/03

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Public Health
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Society medicine;Epidemiology and preventive medicine

Research Keywords

  • Epidemiology
  • Infectious Disease Control and Prevention
  • Theoretical Epidemiology
  • Hepatitis Virus
  • health check system
  • Seroepidemiology
  • Data Health

Affiliated Academic Societies

  • Japan Society of Public Health, 1986
  • Japanese Epidemiological Association, 1986
  • The Japan Society oh Hepatorogy, 1990
  • Japanese Society of Preventive Medicine, 2004
  • The Biometric Society of Japan, 2009
  • The Japanese Society for Hygiene, 2009
  • Japanese Cancer Association, 2011
  • Japan Society for Occupational Health, 2012
  • The Japanese Society of Gastrointestinal Cancer Screening, 2014

Educational Activity

Course in Charge

  1. 2022, Graduate Education (Master's Program) , 1Term, Academic approach to SDGs - A
  2. 2022, Graduate Education (Master's Program) , 2Term, Academic approach to SDGs - A[On-Demand]
  3. 2022, Graduate Education (Master's Program) , 4Term, Japanese Experience of Human Development-Culture, Education, and Health
  4. 2022, Graduate Education (Master's Program) , 4Term, Japanese Experience of Human Development-Culture, Education, and Health[On-Demand]
  5. 2022, Graduate Education (Master's Program) , 3Term, Data Literacy in Medicine
  6. 2022, Graduate Education (Doctoral Program) , 3Term, Utilization of data Literacy in Medicine[On-Demand]
  7. 2022, Undergraduate Education, Intensive, Social Medicine
  8. 2022, Undergraduate Education, 2Term, Introduction for medical research
  9. 2022, Undergraduate Education, 2Term, Outline of the Global Leadership Role
  10. 2022, Undergraduate Education, Intensive, Practice for medical research
  11. 2022, Graduate Education (Master's Program) , First Semester, Seminar
  12. 2022, Graduate Education (Master's Program) , Second Semester, Seminar
  13. 2022, Graduate Education (Master's Program) , First Semester, Research
  14. 2022, Graduate Education (Master's Program) , Second Semester, Research
  15. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar
  16. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar
  17. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research
  18. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research
  19. 2022, Graduate Education (Master's Program) , 1Term, Seminar on Health Policy & Global Health
  20. 2022, Graduate Education (Master's Program) , 2Term, Basic Biostatistics and Basic Clinical Statistics
  21. 2022, Graduate Education (Master's Program) , First Semester, Research on Public Health (Epidemiology)
  22. 2022, Graduate Education (Master's Program) , Second Semester, Research on Public Health (Epidemiology)
  23. 2022, Graduate Education (Master's Program) , Second Semester, Research on Public Health (Epidemiology)
  24. 2022, Graduate Education (Master's Program) , First Semester, Research on Public Health (Biostatistics)
  25. 2022, Graduate Education (Master's Program) , Second Semester, Research on Public Health (Biostatistics)
  26. 2022, Graduate Education (Master's Program) , First Semester, Basic Epidemiology and Practice
  27. 2022, Graduate Education (Master's Program) , Second Semester, Basic and Advanced Training on Methodology for Clinical Research
  28. 2022, Graduate Education (Master's Program) , First Semester, Exercise and Seminar on Epidemiological Research and It's Analysis
  29. 2022, Graduate Education (Master's Program) , 3Term, Exercises and Seminar on Medical Statistics Using Statistical Software
  30. 2022, Graduate Education (Master's Program) , 1Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance A
  31. 2022, Graduate Education (Master's Program) , 3Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance B
  32. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Epidemiology,Infectious Disease Control and Prevention
  33. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Epidemiology,Infectious Disease Control and Prevention
  34. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Epidemiology,Infectious Disease Control and Prevention
  35. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Epidemiology,Infectious Disease Control and Prevention
  36. 2022, Graduate Education (Doctoral Program) , Second Semester, Basic and Advanced Training on Methodology for Clinical Research

Award of Education

  1. 2016/11/05
  2. 2018/11/01

Research Activities

Academic Papers

  1. Fatigue of workers judged from Subjective Symptoms, XI Asian Conference on Occupational Health, 346-351, 19850401
  2. A Recommendation Concerning Toxicity Test on Fish for Various Metals, Toxicology of Metals Clinical and Experimental Research, 133-134, 19870401
  3. The Effects of School Life on Smoking Behavior in Youth, 6Th World Conference on Smoking and Health, 561-563, 19870401
  4. A study on the Connected Items of smoking Habit in Youth and its Countermeasures., Hiroshima J. Med. Sci., 37(1), 37-40, 19880401
  5. Fatigue Caused by Visual Display Terminal Work ; An Experimental Investigation, Hiroshima J. Med. Sci., 38(2), 2, 19890401
  6. A Report of Fatigue in Japanese Contemporary Workers Based on Subjective Symptoms., Journal of UOEH, 11, 622-630, 19890401
  7. Toxicity to Medaka of Solutions of Fenitrothion degradated by strong Alkali, Environmental Pollution, 58, 35-42, 19890401
  8. Effects of Diphenylether Herbicide (CNP) on Mouse Fetuses, Hiroshima J. Med. Sci., 38(3), 125-130, 19890401
  9. The effects of Fenitrothion Emulsion (organic phosphorous pesticide) and Its Degraded Solution on Mice, Hiroshima J. Med. Sci., 38(4), 209-212, 19890401
  10. Toxicity to Fenitrothion Degradation to medaka(oryzias Latipes), Bulletin of Environmental Contamination and Toxicology, 44(2), 210-215, 19900401
  11. Comparison of HCV core antigen activity by ELISA and amount of HCV RNA by branched DNA assay, International Hepatology Communications, 2, 175-177, 19940401
  12. Ultrasound biomicroscopic study of ciliary body thickness after topical application of pharmacologic agents, American Journal of Ophthalmology, 121((3)), 319-321, 19960401
  13. Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan, Journal of Epidemiology, 6(4), 198-203, 19960401
  14. Epidemiology of hepatitis C virus in Japan, Intervirology, 42, 153-158, 19990401
  15. Screening for gastroenterological malignancies in new and maintenance dialysis patients, Journal of Gastroenterology, 34, 35-40, 19990401
  16. Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis, The International Journal of Artificial Organs, 22(1), 14-17, 19990401
  17. High incidence of extrahepatic manifestations in an HCV hyperendemic area, HEPATOLOGY RESEARCH, 22(1), 27-36, 200201
  18. Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients, AMERICAN JOURNAL OF KIDNEY DISEASES, 41(4), 822-832, 200304
  19. ★, Natural histories of hepatitis C virus infection in men and women simulated by the Markov model, JOURNAL OF MEDICAL VIROLOGY, 70(3), 378-386, 200307
  20. Lack of epidemiological evidence for a role of resolved hepatitis B virus infection in hepatocarcinogenesis in patients infected with hepatitis C virus in Japan, INTERVIROLOGY, 46(3), 171-176, 2003
  21. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000, INTERVIROLOGY, 47(1), 32-40, 2004
  22. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission, INTERVIROLOGY, 47(1), 57-64, 2004
  23. Association between ENOS gene polymorphism and cardiovascular events in nondiabetic hemodialysis patients; A prospective study, AMERICAN JOURNAL OF KIDNEY DISEASES, 44(1), 112-120, 200407
  24. Early dynamics of hepatitis C virus in the circulation of chimpanzees with experimental infection, INTERVIROLOGY, 48(2-3), 120-123, 2005
  25. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population, INTERVIROLOGY, 49(1-2), 7-17, 2005
  26. Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003, JOURNAL OF MEDICAL VIROLOGY, 76(4), 498-502, 200508
  27. Prediction of outcomes of assisted reproduction treatment using the calcium ionophore-induced acrosome reaction, HUMAN REPRODUCTION, 20(2), 469-475, 200502
  28. Hepatitis B Virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience, JOURNAL OF CLINICAL VIROLOGY, 36, S56-S64, 200605
  29. Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years, HEPATOLOGY RESEARCH, 37(12), 994-1001, 2007
  30. Epidemiological survey of oral lichen planus among HCV-infected inhabitants in a town in Hiroshima Prefecture in Japan from 2000 to 2003, ONCOLOGY REPORTS, 18(5), 1177-1181, 200711
  31. ★, Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004, INTERVIROLOGY, 51(1), 33-41, 2008
  32. Comparative study on the morphology and the composition of the otoliths in the teleosts, ACTA OTO-LARYNGOLOGICA, 128(8), 846-855, 2008
  33. Titration of Hepatitis B Virus Infectivity in the Sera of Pre-Acute and Late Acute Phases of HBV Infection: Transmission Experiments to Chimeric Mice With Human Liver Repopulated Hepatocytes, JOURNAL OF MEDICAL VIROLOGY, 80(12), 2064-2068, 2008
  34. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C, TRANSFUSION, 48(2), 286-294, 2008
  35. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection, TRANSFUSION, 49(3), 585-595, 2009
  36. Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus, JOURNAL OF GASTROENTEROLOGY, 45(1), 105-112, 2010
  37. Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems, HEPATOLOGY RESEARCH, 40(11), 1082-1091, 2010
  38. Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus, JOURNAL OF GASTROENTEROLOGY, 46(4), 536-544, 2011
  39. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life, OSTEOPOROSIS INTERNATIONAL, 22(5), 1573-1579, 201105
  40. Evaluation of Rebound Tonometer for Measuring Intraocular Pressure at Deviated Angle and Position, CURRENT EYE RESEARCH, 36(5), 422-428, 2011
  41. ★, Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-Specific Prevalence on the National Scale, INTERVIROLOGY, 54(4), 185-195, 2011
  42. Interferon Alone or Combined with Ribavirin for Acute Prolonged Infection with Hepatitis C Virus in Chimpanzees, INTERVIROLOGY, 54(4), 229-232, 2011
  43. Association of Serum Anti-Periodontal Pathogen Antibody with Ischemic Stroke, CEREBROVASCULAR DISEASES, 34(5-6), 385-392, 2012
  44. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 2012
  45. Intraocular Pressure Measurement Using Rebound Tonometer for Deviated Angles and Positions in Human Eyes, CURRENT EYE RESEARCH, 37(2), 109-114, 2012
  46. Follow up of the 987 blood donors found with hepatitis C virus infection over 9-18 years, HEPATOLOGY RESEARCH, 42(7), 637-647, 2012
  47. Corneal displacement during tonometry with a noncontact tonometer, JAPANESE JOURNAL OF OPHTHALMOLOGY, 56(3), 273-279, 2012
  48. Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose Liver Disease, PLOS ONE, 7(10), 2012
  49. Improvement of glycated hemoglobin in Japanese subjects with type 2 diabetes by resolution of periodontal inflammation using adjunct topical antibiotics: Results from the Hiroshima Study, DIABETES RESEARCH AND CLINICAL PRACTICE, 100(1), 53-60, 2013
  50. Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus, JOURNAL OF GASTROENTEROLOGY, 48(4), 515-525, 2013
  51. The Applicability of Ganglion Cell Complex Parameters Determined From SD-OCT Images to Detect Glaucomatous Eyes, JOURNAL OF GLAUCOMA, 22(9), 713-718, 201312
  52. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine, ALLERGY, 68(2), 229-235, 201302
  53. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(2), 357-364, 2013
  54. Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis, JOURNAL OF HEPATOLOGY, 58(3), 427-433, 201303
  55. A tilting embryo culture system increases the number of high-grade human blastocysts with high implantation competence, REPRODUCTIVE BIOMEDICINE ONLINE, 26(3), 260-268, 2013
  56. Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia, JOURNAL OF HEPATOLOGY, 59(5), 1073-1080, 201311
  57. Evaluation of strategies for control and prevention of pandemic influenza (H1N1pdm) in Japanese children attending school in rural town Simulation using mathematical models, 60(4), 204-211, 2013
  58. Inner retinal layer comparisons of eyes with exudative age-related macular degeneration and eyes with age-related macular degeneration and glaucoma, GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 252(4), 563-570, 2014
  59. Using the Early Postoperative Intraocular Pressure to Predict Pressure Control After a Trabeculectomy, JOURNAL OF GLAUCOMA, 23(6), 410-414, 2014
  60. Changes in hepatitis C virus genotype distribution in Japan, EPIDEMIOLOGY AND INFECTION, 142(12), 2624-2628, 201412
  61. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, 2014
  62. Width of abnormal ganglion cell complex area determined using optical coherence tomography to predict glaucoma, JAPANESE JOURNAL OF OPHTHALMOLOGY, 58(1), 47-55, 2014
  63. Validation and limitation of age-period-cohort model in simulating mortality due to hepatocellular carcinoma from 1940 to 2010 in Japan, HEPATOLOGY RESEARCH, 44(7), 713-719, 2014
  64. High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 49(3), 555-563, 201403
  65. ★, Estimating numbers of persons with persistent hepatitis B virus infection transmitted vertically and horizontally in the birth cohort during 1950-1985 in Japan, HEPATOLOGY RESEARCH, 44(10), E181-E188, 2014
  66. Cost-effectiveness of the introduction of low-dose CT screening in Japanese Smokers aged 55 to 74 years old, Hiroshima Journal of Medical Sciences, 63(1-3), 13-22, 2014
  67. Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis B Surface Antigen in Field and Laboratory Settings in the Gambia, Western Africa, JOURNAL OF CLINICAL MICROBIOLOGY, 53(4), 1156-1163, 2015
  68. Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia, HEPATOLOGY RESEARCH, 45(4), 480-487, 2015
  69. Effect of increasing respiratory rate on airway resistance and reactance in COPD patients, RESPIROLOGY, 20(1), 87-94, 201501
  70. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam, HEPATOLOGY RESEARCH, 45(3), 259-268, 2015
  71. Estimated numbers of patients with liver disease related to hepatitis B or C virus infection based on the database reconstructed from medical claims from 2008 to 2010 in Japan, HEPATOLOGY RESEARCH, 45(12), 1228-1240, 2015
  72. Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence, incidence and occult hepatitis B virus infection, HEPATOLOGY RESEARCH, 45(12), 1211-1219, 2015
  73. The association of hepatitis C virus infection with the prognosis of chronic hemodialysis patients: A retrospective study of 3,064 patients between 1999 and 2010, JOURNAL OF MEDICAL VIROLOGY, 87(9), 1558-1564, 2015
  74. Hepatitis E Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4, PLOS ONE, 10(8), 2015
  75. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3, JOURNAL OF VIRAL HEPATITIS, 22, 4-20, 201512
  76. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3, JOURNAL OF VIRAL HEPATITIS, 22, 21-41, 201512
  77. Strategies to manage hepatitis C virus infection disease burden - volume 3, JOURNAL OF VIRAL HEPATITIS, 22, 42-65, 201512
  78. Intraocular pressure readings obtained through soft contact lenses using four types of tonometer, CLINICAL OPHTHALMOLOGY, 9, 1875-1881, 2015
  79. Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation, HEPATOLOGY RESEARCH, 45(11), 1047-1054, 2015
  80. Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones, JOURNAL OF INFECTION, 72(1), 91-102, 2016
  81. Hypothalamic-pituitary-adrenal axis activity is associated with the prevalence of chronic kidney disease in diabetic patients, ENDOCRINE JOURNAL, 63(2), 119-126, 20160220
  82. Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index, JOURNAL OF GASTROENTEROLOGY, 51(4), 380-389, 201604
  83. Follow-up study of the regional quota system of Japanese medical schools and prefecture scholarship programmes: a study protocol, BMJ OPEN, 6(4), 2016
  84. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation, HUMAN IMMUNOLOGY, 77(6), 456-463, 201606
  85. HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics, JOURNAL OF HEPATOLOGY, 65(1), 48-56, 201607
  86. Y Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis, LIVER INTERNATIONAL, 36(6), 817-826, 201606
  87. Key role of heat shock protein 90 in leptin-induced STAT3 activation and feeding regulation, BRITISH JOURNAL OF PHARMACOLOGY, 173(15), 2434-2445, 201608
  88. Reproducibility of optic disk evaluation in supine subjects with a Heidelberg Retina Tomograph II laser tomographic scanner, CLINICAL OPHTHALMOLOGY, 10, 1617-1622, 2016
  89. Systematic review and, meta-analysis of hepatitis C virus infection in the Democratic Republic of Congo, PUBLIC HEALTH, 139, 13-21, 201610
  90. ★, Predicting future blood supply and demand in Japan with a Markov model: application to the sex- and age-specific probability of blood donation, TRANSFUSION, 56(11), 2750-2759, 201611
  91. High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 13(10), 201610
  92. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32(2), 451-458, 201702
  93. Viral eradication reduces all-cause mortality, including nonliver-related disease, in patients with progressive hepatitis C virus-related fibrosis, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32(3), 687-694, 201703
  94. Mustard gas exposure and mortality among retired workers at a poisonous gas factory in Japan: a 57-year follow-up cohort study, OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 74(5), 321-327, 201705
  95. A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients, ONCOLOGY LETTERS, 14(1), 299-305, 201707
  96. Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family, PLOS ONE, 12(7), 20170728
  97. Barrier assessment in establishing comprehensive client-level coordination for treatment and medical welfare of people living with hemophilia and HIV/AIDS in Japan, HAEMOPHILIA, 20, 164-164, 2014
  98. Post-treatment levels of -fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C, HEPATOLOGY RESEARCH, 47(10), 1021-1031, 201709
  99. A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study, SPRINGERPLUS, 5, 20161018
  100. Reduced prevalence of hepatitis B surface antigen positivity among pregnant women born after the national implementation of immunoprophylaxis for babies born to hepatitis B virus-carrier mothers in Japan, HEPATOLOGY RESEARCH, 47(12), 1329-1334, 201711
  101. Differences in the impact of prognostic factors for hepatocellular carcinoma over time, CANCER SCIENCE, 108(12), 2438-2444, 201712
  102. A seroepidemiological survey of the effect of hepatitis B vaccine and hepatitis B and C virus infections among elementary school students in Siem Reap province, Cambodia, HEPATOLOGY RESEARCH, 48(3), E172-E182, 201802
  103. Pilot study for hepatitis virus screening among employees as an effective approach to encourage employees who screened positive to receive medical care in Japan, HEPATOLOGY RESEARCH, 48(3), E291-E302, 201802
  104. Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 47(7), 1012-1022, 201804
  105. ★, Incidence and risk factors of colorectal cancer based on 56324 health checkups: A 7-year retrospective cohort study, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33(4), 855-862, 201804
  106. Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33(4), 918-925, 201804
  107. Efficacy of cognitive-behavioral therapy for patients with temporomandibular disorder pain-systematic review of previous reports, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 11(2), 500-509, 2018
  108. ★, Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011, JOURNAL OF VIRAL HEPATITIS, 25(4), 363-372, 201804
  109. Soft silicone foam dressing is more effective than polyurethane film dressing for preventing intraoperatively acquired pressure ulcers in spinal surgery patients: the Border Operating room Spinal Surgery (BOSS) trial in Japan, INTERNATIONAL WOUND JOURNAL, 15(2), 188-197, 201804
  110. High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies, BMC PUBLIC HEALTH, 18, 20180425
  111. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, LANCET GASTROENTEROLOGY & HEPATOLOGY, 2(3), 161-176, 201703
  112. Cost-effectiveness analyses of anti-hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture, Japan, HEPATOLOGY RESEARCH, 48(7), 509-520, 201806
  113. Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease, Hepatology Communications, 1(i9), 899-910, 2017
  114. Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 48(6), 664-670, 201809
  115. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030, JOURNAL OF HEPATOLOGY, 69(4), 896-904, 201810
  116. Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis, ANNALS OF GASTROENTEROLOGICAL SURGERY, 2(5), 383-393, 201809
  117. ★, Natural course of persistent hepatitis B virus infection in hepatitis B e antigen-positive and hepatitis B e antigen-negative cohorts in Japan based on the Markov model, JOURNAL OF MEDICAL VIROLOGY, 90(12), 1800-1813, 201812
  118. Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients, JCI INSIGHT, 3(20), 20181018
  119. Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model, JOURNAL OF GASTROENTEROLOGY, 53(11), 1196-1205, 201811
  120. Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias, LIVER INTERNATIONAL, 38(12), 2260-2268, 201812
  121. ★, Incidence rates of hepatitis C virus infection among blood donors in Japan: a nationwide retrospective cohort study, TRANSFUSION, 58(12), 2880-2885, 201812
  122. New Diagnostic Criteria for the Localization of Insulinomas with the Selective Arterial Calcium Injection Test: Decision Tree Analysis, JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 29(12), 1749-1753, 201812
  123. ★, Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination, VACCINE, 37(1), 145-151, 20190103
  124. ★, Very low prevalence of anti-HAV in Japan: high potential for future outbreak, SCIENTIFIC REPORTS, 9, 20190206
  125. The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study, LIVER INTERNATIONAL, 39(3), 448-454, 201903
  126. Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis, HEPATOLOGY COMMUNICATIONS, 3(3), 348-355, 201903
  127. ★, Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study, LANCET GASTROENTEROLOGY & HEPATOLOGY, 3(6), 383-403, 201806
  128. Progression of Liver Fibrosis Is Associated With Non-Liver-Related Mortality in Patients With Nonalcoholic Fatty Liver Disease, HEPATOLOGY COMMUNICATIONS, 1(9), 899-910, 201711
  129. ★, A Questionnaire Survey on the Sequence of Events Prior to Undergoing Colonoscopy: The Influence of the Behavioral Response after a Fecal Occult Blood Test on the Early Detection of Colorectal Cancer, INTERNAL MEDICINE, 58(11), 1541-1547, 2019
  130. Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 34(6), 1066-1073, 201906
  131. ★, Natural history of liver-related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model, JOURNAL OF MEDICAL VIROLOGY, 91(10), 1837-1844, 201910
  132. The course of elderly patients with persistent hepatitis C virus infection without hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 54(9), 829-836, 201909
  133. ★, High possibility of hepatocarcinogenesis in HBV genotype C1 infected Cambodians is indicated by 340 HBV C1 full-genomes analysis from GenBank, SCIENTIFIC REPORTS, 9, 20190821
  134. The Pilot Study for Health Check-Ups System at Elementary School in Cambodia, Hiroshima Journal of Medical Sciences, 67(3), 88-92, 2018
  135. ★, Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view, HEPATOLOGY RESEARCH, 49(9), 990-1002, 201909
  136. Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma, SCIENTIFIC REPORTS, 9, 20191031
  137. Alteration of gut microbiota by a Westernized lifestyle and its correlation with insulin resistance in non-diabetic Japanese men, JOURNAL OF DIABETES INVESTIGATION, 10(6), 1463-1470, 201911
  138. The emergence of non-hypervascular hypointense nodules on enhanced MRI in patients with chronic hepatitis C, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 50(11-12), 1232-1238, 201912
  139. Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade, HEPATOLOGY RESEARCH, 49(10), 1218-1226, 201910
  140. Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 34(11), 2011-2018, 201911
  141. Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 31(11), 1452-1459, 201911
  142. Liver stiffness does not affect ultrasound-guided attenuation coefficient measurement in the evaluation of hepatic steatosis, HEPATOLOGY RESEARCH, 50(2), 190-198, 202002
  143. The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey, BMC INFECTIOUS DISEASES, 20(1), 20200115
  144. Existence of hepatitis B virus surface protein mutations and other variants: demand for hepatitis B infection control in Cambodia, BMC INFECTIOUS DISEASES, 20(1), 20200425
  145. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017, VACCINE, 37(35), 5059-5066, 20190814
  146. Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer, CANCER SCIENCE, 111(5), 1856-1861, 202005
  147. Meta-regression analysis of sex-and birth year-specific prevalence of HBsAg and anti-HCV among un-.diagnosed Japanese: Data from the first-time blood donors, periodical health checkup, and the comprehensive health checkup with lifestyle education, Journal of Epidemiology, 2019
  148. Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers, Scientific Reports, 10(1), 3857-3857, 2019
  149. Comparison of liver disease state progression in patients with eradication of versus persistent infection with hepatitis C virus: Markov chain analysis, JOURNAL OF VIRAL HEPATITIS, 28(3), 538-547, 202103
  150. Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis, JOURNAL OF VIRAL HEPATITIS, 28(3), 508-516, 202103
  151. A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma, HPB, 23(1), 134-143, 202101
  152. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan, PLOS ONE, 16(2), 20210205
  153. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113(4), 576-585, 202104

Invited Lecture, Oral Presentation, Poster Presentation

  1. Epidemiological Assessment of the interventions for elimination of mother-to-child transmission of hepatitis B virus in Japan, Tanaka J, Sugiyama A, Ko K, Yamamoto C, AASLD The Liver Meeting 2019, 2019/11/09, Without Invitation, English
  2. Epidemiological trends in viral hepatitis B and C in Japan, Tanaka J, HEPATITIS CLINICAL FORUM, 2019/10/29, With Invitation, Japanese
  3. Epiemiology of viral hepatitis, Tanaka J, 5th Scietific and Practical conference on the problem of infectious Diseases, 2019/09/05, With Invitation, English
  4. Epidemiology of hepatitis B virus in Japan and Asia, Tanaka J, 2018/11/01, Without Invitation, Japanese
  5. Epidemiology of HBV and HCV infections in Japan from the viewpoint of viral hepatitis eradication, Tanaka J, The 3rd MYONGJI INTERNATIONAL LIVER SYMPOSIUM, 2018/09/07, With Invitation, English
  6. The sero-epidemiological study on the prevalence of hepatitis B among children and mother in Cambodia., Tanaka J, VHPB (Viral Hepatitis Prevention Board)ASIA MEETING Prevention and control of hepatitis B with combined vaccines, and timely birth dose vaccination, 2018/07/25, With Invitation, English
  7. Pathway from the Epidemiological Point of View; Moving towards the Elimination of HBV & HCV in Japan, Tanaka J, 2018 APASL Single Topic Conference on Hepatitis B Virus Taipei, 2018/06/23, With Invitation, English, Taipei,Taiwan
  8. (Moderator) Plenary Session(I):Epidemiology Impacts of secondary and TertiaryPrevention in Choronic Hepatitis B Elimination, Tanaka J, 2018/06/23, With Invitation, Japanese
  9. Sero-prevalence of hepatitis B surface antigen among 5-7 years old children and their mothers in Cambodia by nationwide multi-stage stratified random sampling strategy , Tanaka J, Woodring J, Vichit O, Wasley A, Bunsoth M, Nagashima S, Yamamoto C, Chuon C, Ko K, Md Hossain MS, 53rd the international liver congress 2018 (EASL), 2018/04/12, With Invitation, English
  10. HBV prevalence estimated by nationwide survey in Cambodia, Tanaka J, ANRS Cambodian site scientific days, 2018/01/23, With Invitation, English
  11. HBV prevalence in Vietnam, United States-Japan Cooperative Medical Science Program (USJCMSP) 20th International Conference on Emerging Infectious Diseases, 2018/01/10, With Invitation, English
  12. Economic impact of HCV treatment-Japan, 2015-2030, Tanaka J, AASLD THE LIVER MEETING 2017, 2017/10/20, Without Invitation, English
  13. Economic impact of HCV treatment-Japan, 2015-2030, Tanaka J, Estes C, Razavi H, 24th International Symposium on Hepatitis C virus and Related Viruses(HCV2017), 2017/09/25, Without Invitation, English
  14. Epidemiology of HBV and HCV infections from the viewpoints of eradication of liver cancer, Tanaka J, APASL(Asian Pacific Association for the Study of the Liver-Single Topic Conference 2017), 2017/04/11, With Invitation, English
  15. HBV screening, Further improvement of blood safety. -based on the knowledge deduced from the results on analysis of the donor's sera positive for HBV DNA by NAT as well as the results of experimental HBV infection to Chimpanzees-, Tanaka J, Yoshizawa H, SoGAT XVIII, 2005/05, Without Invitation, English

Social Activities

Other Social Contributions

  1. A grateful America Chamber of Commerce in Japan (ACCJ) Healthcare Committee & Pharmaceuticals Subcommittee Meeting, topics on hepatitis C and hepatitis B from an epidemiological viewpoint, 2012/07/27, 2012/07/27, Lecturer, Lecture
  2. The 28th Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region, 2019/06/18
  3. EASL The Hepatology Day in Uzbekistan within the framework of the Conference "Topical aspects of viral infections", 2018/02, Others
  4. 20th International Conference on Emerging Infectious Disease(EID) in the Pacific Rim, Shenzhen, China, 2018/01, Lecturer
  5. ANRS Cambodian site scientific days in Cambodia, 2018/01, Lecturer
  6. IPFA/PEI 24th Inernational Workshop on Surveillance and Screening of Blood-borne Pathogens,Zagreb,Croatia, 2017/05, Panelist